Skip to main content
Research project

Blood-brain barrier permeability, inflammation, and clinical progression in Alzheimer’s disease

Project overview

i. It is imperative that we undertake research into the causes of Alzheimer’s disease (AD). Also, the exploration of why some people with AD decline faster than others is an understudied area. The role of inflammation has been established as a key factor in the aetiology and progression of AD. The mechanism via which peripheral inflammation may cause neuroinflammation is likely to involve the blood-brain barrier (BBB). The BBB is vital in maintaining homeostasis in the brain. We have validated a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) technique that can detect subtle changes in BBB permeability. We will recruit 50 people with AD and 20 control participants into a clinical study to examine the role of BBB permeability and peripheral inflammation. We will determine their relationship with clinical progression by assessing people with AD over two years.

ii. Aims 1. To compare BBB permeability between AD and controls at baseline. 2. To analyse the relationship between BBB permeability and peripheral inflammation in AD at baseline. 3. To determine the relationship between BBB permeability at baseline and clinical progression in AD. 4. To identify whether BBB permeability at baseline and peripheral inflammation combine to affect clinical progression in AD.

iii. This research will enhance our understanding of the mechanisms by which BBB permeability and peripheral inflammation affect clinical progression in AD, thereby opening avenues for drug discovery and development. Our study will also determine whether DCE-MRI could be developed into a prognostic biomarker for AD.

Staff

Lead researcher

Dr Jay Amin BM, MRCPsych, PhD

Assoc Prof in Psychiatry of Older Age

Research interests

  • Developing our understanding of the role of inflammation in Lewy body dementia and Alzheimer's disease, including how it affects disease progression.
  • Undertaking cohort studies exploring clinical outcomes in dementia.
  • Undertaking clinical trials testing novel treatments in dementia.
Connect with Jay
Other researchers

Professor Ian Galea MD FRCP PhD

Prof (Clinical & Experimental Neurology)

Research interests

  • Brain haemorrhage: pathophysiology
  • Blood-brain barrier and immune-brain signalling
  • Neuroimmunology
Connect with Ian

Professor Jessica Teeling

Prof of Experimental Neuroimmunology

Research interests

  • Neuroimmunology
  • Systemic inflammation
  • Oral microbiome
Connect with Jessica

Collaborating research institutes, centres and groups

Research outputs